Clinical Trial Update: Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating pharmacogenomics-based therapy for pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: Osaka University | Conditions: Pulmonary Tuberculosis | Phase 4 | Status: COMPLETED